Deciphering mechanisms underlying breast cancer to improve patient outcomes [ 1/1/2021 - 12/31/2025 ]

Research Grant

Brief description Breast cancer is a highly heterogeneous disease. Patients are often treated in a ‘one size fits all’ approach, but response to therapy remains disparate. To more effectively personalise therapy, there is a pressing need to define the precise cell types and initiating genetic events that give rise to breast cancer. This application is centred on understanding mechanisms of breast cancer initiation and progression, with the potential of identifying new prognostic markers and therapeutic targets.

Funding Amount $3,314,215

Funding Scheme Investigator Grants

Chief Investigator Prof Jane Visvader

Notes Leadership 3